Kenyon, Katherine Hope http://orcid.org/0000-0003-0222-9565
Boonstra, Frederique
Noffs, Gustavo
Butzkueven, Helmut
Vogel, Adam P.
Kolbe, Scott
van der Walt, Anneke
Funding for this research was provided by:
Monash University
Article History
Accepted: 15 June 2022
First Online: 27 June 2022
Declarations
:
: Anneke van der Walt served on advisory boards and receives unrestricted research grants from Novartis, Biogen, Merck, and Roche. She has received speaker’s honoraria and travel support from Novartis, Roche, and Merck. She receives grant support from the National Health and Medical Research Council of Australia and MS Research Australia. Adam Vogel is Chief Science Officer of Redenlab Inc. Gustavo Noffs works in scientific development for Redenlab Inc. Scott Kolbe receives grant income from MS Research Australia and has received honoraria from Novartis, Biogen, and Merck. Helmut Butzkueven’s institution receives compensation for serving on scientific advisory boards and speaker bureaus for Biogen, Novartis, Roche, Merck, and UCB, steering committee duties for trials conducted by Biogen, Merck, Roche, and Novartis and his institution receives research support from Merck, Roche, Novartis, ALexion, and Biogen.